Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan

INTRODUCTION: Comparison of the effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors (TKIs) would improve patients’ clinical benefits and save costs. Using real-world data, this study attempted to directly compare the effectiveness and cost-effectiveness of first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Szu-Chun, Lai, Wu-Wei, Hsu, Jason C., Su, Wu-Chou, Wang, Jung-Der
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141611/
https://www.ncbi.nlm.nih.gov/pubmed/32267879
http://dx.doi.org/10.1371/journal.pone.0231413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141611/
https://www.ncbi.nlm.nih.gov/pubmed/32267879
http://dx.doi.org/10.1371/journal.pone.0231413

Ejemplares similares